arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

CytomX Therapeutics, Inc.

CTMX

$2.93 ▲ +0.16 (+5.78%) at close

14 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

CytomX Therapeutics, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $404.2M

Dividend Yield —

Revenue Growth -44.8% ↘

Op. Margin -29.3% ↘

ROIC -22.9% ↗

FCF / Share $-0.55 ↗

Trailing P/E —

Price / Book 5.0x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 22, 2026.

14-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$76.20M

↓ -44.8% —

Net Income Profit after all expenses

$-17.37M

↓ -154.5% —

Operating Margin Operating profit as % of sales

-29.3%

↓ -262.2% 8th

FCF / Share Free cash flow per share

$-0.55

↑ +46.4% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Revenue Growth YoY (%)	-44.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-660%)	36.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+356%)	90.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1030%)	42.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+431%)	-62.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-885%)	74.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+832%)	-3.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-142%)	-16.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-312%)	376.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4602%)	95.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1088%)	51.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+549%)	471.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5797%)	—	—
Net Income Growth YoY (%)	N/M	N/M	99.4% Excellent ↑ Excellent Improving Year-over-year change in net income	14.3% Fair ↑ Fair Improving Year-over-year change in net income	-252.3% Weak ↓ Weak Declining Year-over-year change in net income	67.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-20.8% Weak ↑ Weak Improving Year-over-year change in net income	-96.3% Weak ↓ Weak Declining Year-over-year change in net income	26.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-66.5% Weak ↓ Weak Declining Year-over-year change in net income	-16.7% Weak Weak Year-over-year change in net income	-100.2% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	46.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-33.0% Weak ↓ Weak Declining Year-over-year change in free cash flow	55.0% Excellent Excellent Year-over-year change in free cash flow	9.0% Fair Fair Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	12.8% Good ↓ Good Declining Compound annual revenue growth over 3 years	54.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	0.3% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-2.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-14.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	11.9% Good ↓ Good Declining Compound annual revenue growth over 3 years	56.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	97.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	141.6% Excellent Excellent Compound annual revenue growth over 3 years	156.8% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	-5.4% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	19.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	11.2% Good ↓ Good Declining Compound annual revenue growth over 5 years	-5.8% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	19.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	67.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	62.5% Excellent Excellent Compound annual revenue growth over 5 years	131.9% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Operating Margin (%) (%)	-29.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-296%)	18.1% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+21%)	-6.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-143%)	-190.6% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1371%)	-311.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2173%)	-48.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-423%)	-192.9% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1386%)	-130.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-973%)	-64.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-531%)	-396.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2741%)	-430.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2970%)	—	—	—
Effective Tax Rate (%) (%)	-1.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	117.1% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	29.7% Caution ↑ Caution Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-20.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-22.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-290%)	23.1% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+92%)	-0.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-105%)	-186.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1657%)	-310.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2688%)	-32.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-373%)	-177.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1582%)	-142.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1285%)	-60.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-601%)	-391.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3363%)	-458.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3922%)	—	—	—
FCF Margin (%) (%)	-99.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-62.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-56.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-211.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-323.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	2.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-250.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-133.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	235.7% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—
FCF / Net Income (x)	4.36x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	-2.72x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	99.96x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.13x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	-0.09x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	1.41x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	-3.92x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Return on Invested Capital (%)	-22.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5443.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	118.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	25281.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-68.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-216.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-71.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-65.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-75.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	38.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	33.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-14.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	20.7% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-3.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-38.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-16.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-40.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-17.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-217%)	—	1.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-92%)	115.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+672%)	—	-66.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-540%)	-200.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1433%)	-64.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-531%)	-61.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-511%)	-75.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-600%)	-28.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-287%)	38.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+157%)	34.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+128%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	-0.02x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-103%)	—	—
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	-19.17x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-61.12x Weak Weak Operating income divided by interest expense Optimal: > 5x	-58.88x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-12.67M	$-38.05M	$-17.17M	$-193.65M	$-205.53M	$-191.86M	$-188.43M	$-247.58M	$-177.55M	$-104.64M	$-59.82M	$-62.83M	$-8.70M	$-14.75M
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	—	-0.05x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Revenue per Share (USD)	$0.55	$1.64	$1.37	$0.81	$0.58	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.55	$-1.02	$-0.77	$-1.71	$-1.88	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.58	$-0.01	$-0.70	$-1.29	$-0.01	$1.03	$1.12	$2.90	$1.82	$2.15	$3.50	$-78.82	—	—
Tangible Book Value per Share (USD)	$0.58	$-0.02	$-0.72	$-1.31	$-0.02	$1.01	$1.10	$2.88	$1.79	$2.12	$3.42	$-81.52	—	—
Basic Weighted Avg Shares (shares)	137.94M	84.44M	73.81M	65.74M	64.15M	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Working Capital (USD)	$97.31M	$21.53M	$27.02M	$84.49M	$232.43M	$223.09M	$217.75M	$347.57M	$327.45M	$152.38M	$174.01M	$55.69M	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	$1.57M	—	—
Total Equity (USD)	$99.01M	$-456.00K	$-47.45M	$-85.75M	$-459.00K	$49.80M	$51.11M	$130.88M	$69.90M	$78.48M	$126.07M	$-78.54M	$-44.28M	$-26.05M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Sales/Revenue/Turnover (USD)	$76.20M	$138.10M	$101.21M	$53.16M	$37.31M	$100.36M	$57.49M	$59.50M	$71.62M	$15.04M	$7.71M	$5.08M	$888.00K	—
Depreciation Expense (USD)	$1.20M	$1.60M	$2.00M	$2.30M	$2.60M	$2.40M	$2.50M	$1.70M	$1.50M	$1.70M	—	—	—	—
Net Income, GAAP (USD)	$-17.37M	$31.87M	$-569.00K	$-99.32M	$-115.87M	$-32.88M	$-102.24M	$-84.60M	$-43.10M	$-58.90M	$-35.37M	$-30.31M	$-15.14M	—
Operating Cash Flow (USD)	$-75.59M	$-86.23M	$-56.03M	$-110.79M	$-119.03M	$5.26M	$-140.48M	$-75.52M	$170.37M	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 14 years · 51 quarters

CytomX Therapeutics, Inc.

Analytical Summary

14-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CTMX with peers